Antibodies News and Research

RSS

Study about cells producing group E antibodies would help fight against allergies

Researchers of Sechenov University together with their colleagues from Russia and Austria summarized everything known about cells producing group E antibodies

25 Nov 2019

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomized phase III study reported at the ESMO Asia 2019 Congress.

22 Nov 2019

Cochrane review provides information on HPV vaccines and dose schedules in young women, men

New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus vaccines and vaccine schedules in young women and men.

22 Nov 2019

Eastern equine encephalitis virus poses emergent threat in the U.S.

Although eastern equine encephalitis (EEE), a mosquito-borne illness, has existed for centuries, 2019 has been a particularly deadly year for the disease in the United States.

21 Nov 2019

Public health officials announce that eastern equine encephalitis virus is an “emergent threat”

Public health officials have declared that the mosquito-borne eastern equine encephalitis (EEE) virus is an "emergent threat".

21 Nov 2019

Experimental vaccine elicits antibodies that can neutralize multiple HIV strains

An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.

21 Nov 2019

Researchers discover a peptide involved in both migraine and opioid-overuse pain

About 10% of the world population suffers from migraine headaches, according to the National Institute of Neurological Disorders and Stroke.

20 Nov 2019

ETVAX vaccine candidate shows promise against enterotoxigenic E. coli diarrhea

University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.

20 Nov 2019

Vaccination against HIV can be counterproductive if it triggers the wrong type of immune response

A discovery could help immunologists design vaccines that are more effective in protecting against HIV infection.

20 Nov 2019

Applying a Proteomics-based Approach to the Clinic

Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.

From Bruker Daltonics 20 Nov 2019

Malaria research advances immunotherapy in lupus, HIV

A new study published on November 19, 2019, in the journal Cell Reports, shows how the body’s immune system responds to malaria, which in turn promises to teach scientists how to design more effective therapies for a range of illnesses that are modulated by the immune response.

19 Nov 2019

New microfluidics device detects malignant multiple myeloma cells in blood

Scientists have developed a microfluidics device that could be used for the detection or monitoring of multiple myeloma.

19 Nov 2019

Yale study uncovers why belly fat surrounding organs increases as people age

A study by researchers at Yale has uncovered why belly fat surrounding organs increases as people age, a finding that could offer new treatment possibilities for improving metabolic health, thereby reducing the likelihood for diseases like diabetes and atherosclerosis that stem from inflammation.

15 Nov 2019

Four important tips to stay safe and healthy during winter

Colder temperatures, inclement weather, changes in the amount of daylight, and the spread of cold and flu viruses can all have a significant impact on your winter well-being, making it more challenging for you to stay safe and healthy.

15 Nov 2019

Promising method to identify aggressive breast cancers that will respond to immunotherapy

University of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a promising method to identify aggressive breast cancer tumors that will respond to drugs that unleash the immune system against cancer.

14 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

Blocking metastasis-promoting enzyme can prevent spread of breast cancer

In a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.

14 Nov 2019

Lonza launches new basal and feed medium to optimize protein production

Lonza has further expanded its cell culture media portfolio with the addition of the eCHO Basal Medium and Feed, which has been designed to optimize protein production by delivering a consistent yield and highly viable cells while keeping lactate levels to a minimum for optimal protein integrity.

From Lonza 14 Nov 2019

Researchers find mechanism that controls the growth of B1-cells

Directly after birth, the immune system completes production of a subtype of antibody-producing immune cells, B-1, that are to last for a lifetime. No more B1-cells are formed after that point. However, these cells are self-reactive - they produce not only antibodies against foreign substances, but also against the body's own substances, and it is unclear why the immune system allows for the development of these particular cells.

13 Nov 2019

Researchers take major step towards developing a viable vaccine for malaria

Researchers have narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against the most severe forms of malaria.

13 Nov 2019

Antibodies News and Research

Study about cells producing group E antibodies would help fight against allergies

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Cochrane review provides information on HPV vaccines and dose schedules in young women, men

Eastern equine encephalitis virus poses emergent threat in the U.S.

Public health officials announce that eastern equine encephalitis virus is an “emergent threat”

Experimental vaccine elicits antibodies that can neutralize multiple HIV strains

Researchers discover a peptide involved in both migraine and opioid-overuse pain

ETVAX vaccine candidate shows promise against enterotoxigenic E. coli diarrhea

Vaccination against HIV can be counterproductive if it triggers the wrong type of immune response

Applying a Proteomics-based Approach to the Clinic

Malaria research advances immunotherapy in lupus, HIV

New microfluidics device detects malignant multiple myeloma cells in blood

Yale study uncovers why belly fat surrounding organs increases as people age

Four important tips to stay safe and healthy during winter

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

Blocking metastasis-promoting enzyme can prevent spread of breast cancer

Lonza launches new basal and feed medium to optimize protein production

Researchers find mechanism that controls the growth of B1-cells

Researchers take major step towards developing a viable vaccine for malaria

Industry Focus eBook - Cell biology (5th edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo